2-(1,4-Dioxaspiro[4.5]decan-8-yl)ethanamine

Catalog No. :
ACTQCY309
CAS No. :
124499-34-9
Molecular Formula :
C10H19NO2
Molecular Weight :
185.27

IUPAC Name:2-(1,4-dioxaspiro[4.5]decan-8-yl)ethan-1-amine

2-(1,4-Dioxaspiro[4.5]decan-8-yl)ethanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$150.00Login to see priceIn stockInquiry
250mg95%$199.00Login to see priceIn stockInquiry
500mg95%$333.00Login to see priceIn stockInquiry
1g95%$498.00Login to see priceIn stockInquiry
5g95%$1496.00Login to see priceInquiryInquiry
10g95%$2484.00Login to see priceInquiryInquiry
25g95%$5463.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(1,4-Dioxaspiro[4.5]decan-8-yl)ethanamine
IUPAC Name2-(1,4-dioxaspiro[4.5]decan-8-yl)ethan-1-amine
MDL No.MFCD04114534
Molecular FormulaC10H19NO2
Molecular Weight185.27
SMILESNCCC(CC1)CCC21OCCO2
InChI KeySSPKQTFXNGPRNV-UHFFFAOYSA-N
Synonym124499-34-9 | 2-(1,4-dioxaspiro[4.5]decan-8-yl)ethanamine | 2-(1,4-DIOXA-SPIRO[4.5]DEC-8-YL)-ETHYLAMINE | 1,4-Dioxaspiro[4.5]decane-8-ethanamine | MFCD04114534 | 2-(1,4-Dioxa-spiro[45]dec-8-yl)ethylamine | 2-{1,4-dioxaspiro[4.5]decan-8-yl}ethan-1-amine | 2-(1,4-DIOXASP
CAS No.124499-34-9
PubChem CID10058234

Safety Data

Pictogram
Corrosive
Signal Word
Gefahr
Hazard Statement(s)
H318
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACTQCY309 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTQCY309 route product structure diagram
    ACTQCY309124499-34-9 In Stock
Inquiry

2. ACTQCY309 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTQCY309 route product structure diagram
    ACTQCY309124499-34-9 In Stock
Inquiry

Comments (0)